CS Paper Radar

Annotating anatomy and pathology in the National Lung Screening Trial computed tomography images

Deepa Krishnaswamy, Vamsi Thiriveedhi, Suraj Pai, David Clunie, Igor Octaviano, Christopher P. Bridge, Steve Pieper, Ron Kikinis, Andrey Fedorov

eess.IV ·submitted 2026-09-09 21:52 UTC · v1

Abstract

Large-scale public medical imaging datasets contribute critically to translational research. When accompanied by rich clinical and multi-omics data, they can stimulate exploratory research and enable secondary analyses. Expert annotations of such imaging collections can support the development of new image analysis tools. Continuous enrichment of images with image-derived data makes them more usable for researchers without expertise in image analysis or access to large-scale computational resources. The National Lung Screening Trial (NLST) released a rich longitudinal dataset that includes Computed Tomography (CT) images for over 26,000 patients. We introduce three Digital Imaging and Communications in Medicine (DICOM) formatted datasets, complementing NLST CT images, shared as analysis results in the National Cancer Institute Imaging Data Commons (IDC). Two of those (IDC NLSTSeg and IDC NLSTSybil) contain DICOM-harmonized annotations and extracted measurements (for 581 and 601 NLST patients, respectively) shared earlier using research formats (Sybil and NLSTseg). The third one (TotalSegmentator-CT-Segmentations) contains volumetric segmentations generated using TotalSegmentator and radiomics features for each segment for 26,194 NLST patients.

Closest papers

Nearest neighbours by meaning across the whole index.

LUCQUE: A lung cancer screening dataset from Québec for reliable AI evaluation

cs.DB cs.AI ·2026-11-09 ·Johanna Topalis, Yannick Lemaréchal, Gabriel Couture, Hanife Ersay, Loran Nas +5 more
similarity 0.76
Abstract

BACKGROUND: AI-based tools are expected to play a key role in lung cancer screening (LCS). The evaluation of these tools often relied on private datasets or fragmented public datasets with inconsistent availability of clinical data and expert nodule annotations. This has hindered reproducibility, comparability, and independent assessment of AI tools. To address these gaps, we present LUCQUE, a novel, large, comprehensively annotated dataset derived from LDCT lung cancer screening in Québec, which is accessible for reliable AI evaluation. METHODS: LUCQUE was curated and is hosted on PARADIM, a digital infrastructure supporting DICOM data de-identification, annotation, long-term storage and analysis. LDCT scans and clinical information were combined to a curated collection and complemented by voxel-level, expert-derived pulmonary nodule and cyst segmentations, and Lung-RADS-based lesion characteristics. Key dataset characteristics and statistics were reported, including participant demographics, imaging parameters, radiological findings, and segmented lesion characteristics. Dataset analyses were conducted according to PARADIM's model-to-data approach, in which user code is executed on the platform such that data remains on premise. RESULTS: LUCQUE currently comprises 1,678 LDCT baseline studies from 1,678 participants. Most studies were classified as Lung-RADS 2. A total of 1,776 pulmonary nodules and 60 cysts were annotated, with a median (interquartile range) volume of $89\,(56,\,159)\,\mathrm{mm}^3$ and $1,384\,(589,\,3793)\,\mathrm{mm}^3$ respectively. CONCLUSIONS: Compared to publicly available LCS datasets, LUCQUE currently represents the largest accessible annotated real-world LCS dataset. Access to LUCQUE is provided via a model-to-data approach, enabling privacy-preserving, reproducible, and independent real-world evaluation of AI tools in LCS.

0.18

NoduleFlow: Automatic 3D Lung Nodule Detection and Segmentation

cs.CV ·2026-10-12 ·Giulia Romoli, Filippo Ruffini, Francesco Di Feola, Valerio Guarrasi, Matteo Tortora +1 more
similarity 0.73
Abstract

Low dose Computed Tomography (CT) is the standard imaging modality for lung cancer screening. On CT scans, lung cancer typically manifests as pulmonary nodules, whose manual identification is time-consuming and prone to observer variability, image quality limitations, and suboptimal reading conditions. Moreover, subtle temporal changes are often difficult to quantify reliably in CT scans from the same patient across follow-up examinations. Deep learning-based approaches for the automatic detection and segmentation of lung nodules have demonstrated improved accuracy and efficiency. However, most existing approaches provide only coarse region-of-interest localisation, rely on prior lesion annotations or human supervision, or treat detection and segmentation as separate tasks. In this work, we present NoduleFlow, a framework for lung nodule detection, classification, and segmentation directly from series of CT volumes. Our proposal consists of four interconnected modules and operates in an automated manner at inference time, without requiring prior lesion annotations, manual initialisation, or region-of-interest pre-selection. We further investigate whether nodule localization benefits from the propagation of candidate regions across follow-up scans through inter-scan registration fields, as opposed to conventional independent per-scan analysis. The generalisability of the framework is systematically evaluated across four independent datasets. The results underscore the potential of automated pipelines for lung nodule analysis in screening and diagnostic settings.

0.14

Sharing standardized image-derived data in computational pathology using DICOM

cs.CV cs.AIcs.LG ·2026-09-13 ·Daniela P. Schacherer, Christopher P. Bridge, David Clunie, Igor Octaviano, André Homeyer +11 more
code/data similarity 0.72
Abstract · Daniela P. Schacherer, Christopher P. Bridge: contributed equally

Development and evaluation of computational pathology methods require access to large and diverse datasets. Over the past decade, various initiatives invested significantly into collecting, centralizing, and sharing pathology imaging data. In contrast, sharing of image-derived data such as region-of-interest delineations or segmentation masks is less well developed. In this work, we describe our approach to encoding and sharing image-derived pathology data in a standardized manner within the National Cancer Institute (NCI) Imaging Data Commons (IDC), a platform that hosts and provides public access to de-identified radiology and pathology data. The IDC relies on the Digital Imaging and Communications in Medicine (DICOM) standard for data harmonization, yet the adoption of DICOM for pathology image-derived content has remained largely unexplored until now. Here, we present five representative datasets harmonized by conversion from their original representations into DICOM and shared publicly in the IDC. We demonstrate the benefits of this harmonization, describe contributions to critical open-source tooling, and discuss technical considerations relevant to broader adoption of DICOM for pathology image-derived data.

0.22

Disentangling Lung-Cancer CT/LDCT AI: A Systematic Evidence Map of Clinical Tasks, Evidence Chains, and Translational Gaps

cs.LG ·2026-09-28 ·Surajit Das
similarity 0.72
Abstract

Artificial-intelligence studies using computed tomography (CT) for lung cancer are often broadly labelled "prediction" despite addressing clinically distinct tasks. We systematically mapped CT/low-dose CT (LDCT)-centered lung-cancer AI using five-database retrieval, full-text eligibility assessment, role-aware modality/omics extraction, clinical-task classification, and a Multi-Tier Evidence Graph (MTEG). The final corpus comprised 293 studies (2016-2026): 230 Detection, 8 future Risk-prediction, and 55 Other studies. Clinical variables (96.2%), 3D CT/LDCT (73.0%), and radiomics (63.5%) predominated, whereas external validation (29.0%), calibration (20.5%), decision-curve analysis (13.0%), longitudinal CT (17.7%), and saliency/attribution XAI (21.5%) were less frequent. The MTEG comprised 377 nodes and 3,444 edges; only 31 studies (10.6%) completed the six-tier substantive evidence chain, with greatest attrition at reasoning/explanation. Overall, the literature is detection-dominated, genuine future risk prediction remains uncommon, and complete translational evidence chains are rare.

0.08

Can Unsupervised Methods Outperform Supervised Deep Learning When Ground Truth Is Sparse? A Case Study of Bronchovascular Bundle Segmentation in Low-Dose CT

cs.CV ·2026-08-17 ·Anna Mrukwa, Marek Socha, Aleksandra Suwalska, Agata Durawa, Malgorzata Jelitto +7 more
similarity 0.71
Abstract · 17 pages, 4 figures. Part of this research was submitted to the international conference European Molecular Imaging Meeting 2026

Background Lung cancer remains the deadliest cancer worldwide because it is often diagnosed too late. Effective treatment depends on detection at an early screening stage. However, the growing number of patients and the limited number of radiologists lead to prolonged diagnostic waiting times. In very early stage lung cancer, nodule visibility is further reduced by adjacent blood vessels and airway walls, because nodules are often connected to or supplied by these structures. Task-specific analysis of the bronchovascular bundle is therefore important for efficient nodule detection, and its removal can increase the diagnostic potential of lung cancer screening. Materials and Methods To assess the efficacy of the proposed method, we used series from widely utilized LDCT datasets, including the Duke Lung Cancer Screening (DLCS) dataset and the Pilot Pomeranian Lung Cancer Screening Program. The proposed bronchovascular bundle segmentation pipeline, RONALD, operates on computed tomography images and returns binary masks of vessels and bronchi located in the lung parenchyma. The method includes a preprocessing stage with lung, lobe, and mediastinum segmentation, followed by separate vessel and bronchial tree segmentation. Results The proposed pipeline segmented the bronchovascular bundle in low-dose computed tomography scans while improving nodule retention compared with other segmentation methods: from 93.98% and 90.36% to 100% in DLCS, and from 83.16% and 62.36% to 99.92% in the Pomeranian dataset. Conclusion The resulting segmentations can improve lung nodule detection in the very early stages of lung cancer.

0.12

Real-World Multi-Modal and Longitudinal Lung Cancer Dataset

eess.IV cs.CV ·2026-09-04 ·Rita Cordeiro Mendes, Maria Rita Fonseca Verdelho, Carlos Santiago, Catarina Barata
publishedbenchmarkcode/data similarity 0.68
Abstract · Accepted at ECCV 2026 Workshop on Data Curation & Augmentation in Medical Imaging

Multi-modal learning has demonstrated strong potential in medical applications by integrating heterogeneous data sources such as medical imaging, clinical records, and genomics to improve predictive performance and support clinical decision-making. However, advances in this area are often constrained by two key challenges: the limited availability of well-curated, ready-to-use datasets that accurately reflect real-world conditions, where medical data are frequently collected inconsistently and are often incomplete; and the inherent difficulty of integrating heterogeneous data modalities. In this work, we introduce a newly curated multi-center, multi-modal, and longitudinal dataset designed to support the evaluation of a wide range of learning pipelines under realistic conditions. The dataset comprises a total of 1,365 lung cancer patients and has three imaging modalities (whole-slide images, CT scans, and PET scans), structured clinical data, transcriptomic, and longitudinal follow-up and treatment information. For each imaging modality the dataset contains more than one instance. Moreover, the dataset exhibits substantial and non-uniform missingness across modalities, making it well-suited for studying robust multi-modal fusion strategies. We further provide both uni-modal and multi-modal benchmarks on the task of 12-month overall survival prediction, disease-specific survival, as well as longitudinal benchmark of hazard prediction under severe missing data. Our results show that, despite high levels of missingness, integrating complementary modalities consistently improves predictive performance over uni-modal approaches, highlighting the value of multi-modal fusion in realistic clinical settings. The dataset and benchmark code are available at https://github.com/ritacmendes/MMIST-LUNG.

0.33

Prompt-Guided Interactive Segmentation of Interstitial Lung Disease in Thoracic CT

cs.CV ·2026-08-28 ·Vasilis Dedousis, Lubnaa Abdur Rahman, Lorenzo Brigatο, Ethan Dack, Andreas Christe +6 more
code/data similarity 0.68
Abstract

Accurate segmentation of interstitial lung disease (ILD) patterns is essential for quantitative disease assessment and longitudinal monitoring. However, existing approaches remain limited by relying on dense annotations and producing static predictions that cannot be refined, motivating interactive approaches. While promptable models show promise in interactive segmentation, their adaptation to ILDs remains largely unexplored. To address this gap, we investigate prompt-guided foundation models for ILD refinement and present, to the best of our knowledge, the first adaptation of MedSAM2 for interactive 3D ILD segmentation on thoracic CT. We investigate three fine-tuning strategies and multiple clinically motivated prompts: bounding-boxes (BBox), point, lasso, and scribble. On a dataset spanning seven ILD patterns and healthy lung tissue, full model fine-tuning performed best, improving the average Dice score by 4.7 percentage points over MedSAM2.While BBox prompts achieve the strongest performance, non-native MedSAM2 interactions such as lasso and scribble prompts also prove effective. Finally, we present and evaluate a proof-of-concept end-to-end workflow in which MedSAM2 is initialized from an automatic segmentation prior and subsequently refined using radiologist prompts. Model weights and plug-ins made available at: https://github.com/AIHNlab/ILD-SemiSegTool.

0.21

Comprehensive Benchmarking of Deep Learning Architectures for Lung Cancer Histopathology

cs.CV cs.AI ·2026-08-16 ·Hadi Hasan, Safaa Salman, Lama Sleem, Ralph Mouawad, Ali Chehab
benchmark similarity 0.67
Abstract · 8 pages

Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination. Although deep learning has shown considerable potential in computational pathology, comprehensive benchmarks that integrate tissue classification and region segmentation within a unified analytical framework remain limited. This study presents a two-stage deep learning framework for multi-class tissue classification and pixel-level histopathological region segmentation, accompanied by a systematic comparison of state-of-the-art architectures at each stage. For tissue classification, six models, a custom convolutional neural network, VGG16, DenseNet, MobileNetV3, a custom Vision Transformer, and YOLO11, are evaluated on a combined dataset of 39,000 images derived from LC25000 and LungHist700. The models distinguish between adenocarcinoma, squamous cell carcinoma, and normal lung tissue. YOLO11 achieves the best classification performance, with an accuracy of 98.38%, a five-fold cross-validation accuracy of 98.21 +/- 0.35%, and a macro F1-score of 0.98. For region segmentation, U-Net, ResNet-encoder U-Net, DeepLabV3+, and YOLO11-seg are evaluated using the GlaS gland segmentation benchmark. DeepLabV3+ obtains the highest Intersection over Union of 0.80 and a Dice score of 0.89, while YOLO11-seg achieves a comparable Intersection over Union of 0.79 using approximately 14x fewer parameters. The best-performing classification and segmentation models are subsequently integrated into an end-to-end framework, providing an accurate, computationally efficient, and reproducible baseline for automated histopathological image analysis.

0.40